rfhg_88183.1

Basic information about the TSS

---

TSS ID: rfhg_88183.1 TSS ID(Version3): hg_70177.1 hg_70176.1 Species: human Chr: chr6		Start: 142147194 End: 142147284 Strand: +
Source datasets
Protocol
TSS cluster detected*

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3910043,EH38E2509997)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000367621.1:0 ENST00000367630.9:0 AF151062:0 AK301376:0 BC006989:0 BC022536:0 AL136684:0 AK130738:0 AK000051:0 AF060225:0 AF271994:0 BC005937:0 GeneID: 51534 HGNC/MGI_ID: HGNC:20954 UniProt_ID: Q5TGM0 Q9NP79 Nearer transcript ids and distances:

Gene_name: VTA1 Gene_symbol: VTA1 Gene_synonyms: HSPC228 My012 Gene_source: HGNC:20954

TATA-Box annotation

---

Distance to TSS:	-24
Nearest PromoterID:	NM_016485
Entrez ID:	51534
Nearest Unigene:	Hs.431367
Nearest Refseq:	NM_016485
Nearest Ensembl:	ENSG00000009844
Gene Name:	VTA1
Gene Alias:	C6orf55|DRG-1|DRG1|HSPC228|LIP5|My012|SBP1
Gene Type:	protein-coding
CpG%:	0.122222
GC%:	0.615385
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@VTA1 p2@VTA1
Sample		p1@VTA1	p2@VTA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	51.04	8.57
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	41.68	8.90
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	49.77	8.29
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	41.37	8.32
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	44.54	8.77
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	51.36	7.17
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	76.26	9.15
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	55.71	6.54
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	54.71	6.63
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.85	8.11
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	44.06	11.32
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	8.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	20.79	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.36	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.56	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.60	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.40	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.05	1.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.93	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.75	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.81	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.09	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.18	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	25.23	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	15.99	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	23.16	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.12	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.19	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.10	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.68	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.01	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.85	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.89	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.95	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	21.61	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.05	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.76	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.99	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.78	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	19.58	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.88	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.64	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.59	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.54	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.60	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.13	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	21.57	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	307.83	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.16	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.91	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	134.23	14.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	32.15	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.09	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.74	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.46	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	15.51	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	45.38	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.18	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.15	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.23	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	258.62	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	284.31	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.84	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	22.81	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.46	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.04	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	19.57	0.92
Adipocyte - breast, donor1	11376-118A8	48.15	4.91
Adipocyte - breast, donor2	11327-117E4	32.57	4.01
Adipocyte - omental, donor1	11473-119C6	53.94	4.58
Adipocyte - omental, donor2	11474-119C7	14.20	3.74
Adipocyte - omental, donor3	11475-119C8	19.09	3.68
Adipocyte - perirenal, donor1	11476-119C9	20.42	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	35.23	3.61
Adipocyte - subcutaneous, donor3	11408-118E4	19.81	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	45.57	3.32
Adipocyte differentiation, day04, donor2	13022-139D7	23.16	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	2.79
Adipocyte differentiation, day04, donor4	13028-139E4	28.80	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	52.76	6.03
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	2.90
Adipocyte differentiation, day08, donor3	13026-139E2	20.79	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	28.93	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	28.28	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	24.87	3.27
Adipocyte differentiation, day12, donor3	13027-139E3	23.23	2.95
Adipocyte differentiation, day12, donor4	13030-139E6	18.57	2.74
Alveolar Epithelial Cells, donor1	11510-119G7	18.78	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	16.73	1.80
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.89	0.41
Anulus Pulposus Cell, donor1	11248-116E6	43.37	2.63
Anulus Pulposus Cell, donor2	11463-119B5	17.14	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.71	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.48	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	28.40	2.99
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.12	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	3.88
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.23	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	20.32	4.35
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	32.60	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	40.53	2.80
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	6.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.39	1.96
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	25.72	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.94	3.59
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.54	2.32
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.13	3.26
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	22.81	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	34.91	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	24.51	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	25.65	3.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.07	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.83	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.19	2.89
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	25.15	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.09	3.31
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	21.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	26.45	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	33.11	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.25	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	16.82	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.07	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.01	2.36
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.14	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.59	4.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.75	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.14	3.92
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.67	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	27.72	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.16	2.66
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	29.92	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	2.54
Astrocyte - cerebellum, donor1	11500-119F6	14.86	1.60
Astrocyte - cerebellum, donor2	11580-120F5	4.96	0.34
Astrocyte - cerebellum, donor3	11661-122F5	3.57	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	74.25	4.53
Astrocyte - cerebral cortex, donor2	11316-117D2	45.46	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	46.54	4.47
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	104.94	9.06
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	105.49	10.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	101.73	8.42
Basophils, donor1	12241-129G9	21.71	0.52
Basophils, donor2	12242-129H1	44.38	2.16
Basophils, donor3	12243-129H2	19.84	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	7.55	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	22.60	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	10.82	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	28.97	2.52
Burkitt's lymphoma cell line:DAUDI	10422-106C8	80.69	5.15
Burkitt's lymphoma cell line:RAJI	10476-106I8	88.74	7.22
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	65.23	3.84
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00
CD14+ Monocytes, donor1	11224-116B9	18.03	1.69
CD14+ Monocytes, donor2	11305-117B9	14.29	1.86
CD14+ Monocytes, donor3	11381-118B4	18.44	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	59.16	3.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	51.93	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	61.47	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	38.74	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	26.25	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	38.85	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.42	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.77	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	25.29	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.43	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	20.30	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	37.65	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.69	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	21.65	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.73	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.73	2.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	51.84	2.91
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	19.90	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.85	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.95	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	26.36	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	24.60	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.93	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.33	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.09	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	16.23	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.22	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	30.39	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	16.38	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.70	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	22.27	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	58.20	2.83
CD14+CD16+ Monocytes, donor2	11801-124D1	46.43	2.54
CD14+CD16+ Monocytes, donor3	11912-125G4	54.15	1.73
CD14+CD16- Monocytes, donor1	11788-124B6	58.40	3.43
CD14+CD16- Monocytes, donor2	11799-124C8	44.88	2.45
CD14+CD16- Monocytes, donor3	11910-125G2	68.45	3.34
CD14-CD16+ Monocytes, donor1	11790-124B8	54.86	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	52.92	2.85
CD14-CD16+ Monocytes, donor3	11911-125G3	71.38	2.53
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	71.87	3.39
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	61.10	5.18
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	94.35	4.80
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	97.03	8.04
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	63.88	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	73.73	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	5.27
CD19+ B Cells, donor1	11544-120B5	33.70	4.11
CD19+ B Cells, donor2	11624-122B4	39.90	2.18
CD19+ B Cells, donor3	11705-123B4	36.35	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	124.05	21.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	75.10	15.58
CD34+ Progenitors, donor1	11545-120B6	27.11	1.00
CD34+ Progenitors, donor2	11625-122B5	26.97	6.74
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	77.78	6.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	72.15	6.09
CD4+ T Cells, donor1	11225-116C1	93.19	4.64
CD4+ T Cells, donor2	11306-117C1	42.25	3.06
CD4+ T Cells, donor3	11382-118B5	38.12	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	64.06	3.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	54.58	5.84
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	53.18	2.30
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	75.85	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	63.91	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	59.54	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.88	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	34.01	2.26
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	55.14	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	64.64	4.54
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	69.08	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	62.82	7.59
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	41.14	2.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	39.76	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	90.01	5.17
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	96.47	6.97
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	71.73	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.54	3.71
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	54.37	4.55
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	57.37	3.57
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	62.19	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	54.16	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	90.21	6.54
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	93.53	6.43
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	86.78	6.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	80.96	9.77
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	109.11	11.08
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	110.43	9.57
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	87.78	12.32
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	106.00	7.88
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	91.41	5.54
CD8+ T Cells, donor1	11226-116C2	63.84	1.96
CD8+ T Cells, donor2	11307-117C2	37.54	1.50
CD8+ T Cells, donor3	11383-118B6	65.65	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	40.37	4.36
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	36.19	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	39.94	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	50.14	5.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	40.80	3.84
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	44.34	3.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	42.37	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	40.27	3.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	34.71	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	44.07	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.37	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	40.23	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	29.33	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	26.87	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	25.36	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	42.50	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	41.14	4.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	44.08	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	59.58	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	43.37	4.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	49.69	6.09
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	48.19	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.19	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	32.53	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	34.53	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	43.36	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	4.01
Cardiac Myocyte, donor1	11525-119I4	16.45	0.00
Cardiac Myocyte, donor2	11605-120I3	30.63	0.99
Cardiac Myocyte, donor3	11686-122I3	59.04	4.53
Chondrocyte - de diff, donor1	11261-116G1	52.35	6.59
Chondrocyte - de diff, donor2	11338-117F6	32.69	3.91
Chondrocyte - de diff, donor3	11410-118E6	35.73	2.62
Chondrocyte - re diff, donor2	11339-117F7	76.99	12.53
Chondrocyte - re diff, donor3	11411-118E7	23.05	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	70.00	6.89
Ciliary Epithelial Cells, donor2	11323-117D9	43.82	4.49
Ciliary Epithelial Cells, donor3	11399-118D4	44.16	4.07
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	39.61	4.31
Corneal Epithelial Cells, donor1	11526-119I5	5.27	0.22
Corneal Epithelial Cells, donor2	11606-120I4	7.96	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.65	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	33.18	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.18	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.95	2.38
Dendritic Cells - plasmacytoid, donor1	11228-116C4	44.76	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.07	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	46.46	6.78
Endothelial Cells - Aortic, donor0	11207-116A1	22.35	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	16.12	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	1.57
Endothelial Cells - Artery, donor1	11264-116G4	13.38	0.29
Endothelial Cells - Artery, donor2	11341-117F9	25.41	1.88
Endothelial Cells - Artery, donor3	11413-118E9	17.88	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.14	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.38	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	43.13	3.66
Endothelial Cells - Microvascular, donor1	11265-116G5	15.15	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	18.74	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	9.36	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	40.01	3.60
Endothelial Cells - Thoracic, donor2	11343-117G2	9.96	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	75.17	2.61
Endothelial Cells - Umbilical vein, donor2	11324-117E1	26.94	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	31.02	2.44
Endothelial Cells - Vein, donor1	11267-116G7	14.79	2.28
Endothelial Cells - Vein, donor2	11344-117G3	13.27	1.40
Endothelial Cells - Vein, donor3	11416-118F3	16.64	1.41
Eosinophils, donor1	12244-129H3	45.74	0.00
Eosinophils, donor2	12245-129H4	34.66	0.00
Eosinophils, donor3	12246-129H5	14.27	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.64	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	34.07	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	19.82	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	35.10	3.03
Fibroblast - Aortic Adventitial, donor1	11245-116E3	68.28	6.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	66.33	7.78
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.33	3.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.52	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	38.54	4.32
Fibroblast - Cardiac, donor1	11268-116G8	32.66	1.36
Fibroblast - Cardiac, donor2	11345-117G4	22.74	0.76
Fibroblast - Cardiac, donor3	11417-118F4	22.40	0.47
Fibroblast - Cardiac, donor4	11452-119A3	62.44	5.76
Fibroblast - Cardiac, donor5	11456-119A7	31.98	3.17
Fibroblast - Cardiac, donor6	11460-119B2	40.17	4.09
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.94	2.68
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.57	3.45
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	8.07	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	53.26	4.07
Fibroblast - Dermal, donor1	11269-116G9	18.55	3.05
Fibroblast - Dermal, donor2	11346-117G5	27.36	1.42
Fibroblast - Dermal, donor3	11418-118F5	26.23	2.06
Fibroblast - Dermal, donor4	11450-119A1	34.48	2.49
Fibroblast - Dermal, donor5	11454-119A5	36.46	3.84
Fibroblast - Dermal, donor6	11458-119A9	39.31	3.25
Fibroblast - Gingival, donor1	11237-116D4	61.22	6.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	48.99	7.07
Fibroblast - Gingival, donor2	11318-117D4	49.29	3.16
Fibroblast - Gingival, donor3	11394-118C8	30.94	3.09
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.79	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.66	5.77
Fibroblast - Gingival, donor6 (control)	11922-125H5	46.11	2.98
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.82	2.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.85	3.07
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	56.31	4.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	51.23	3.95
Fibroblast - Gingival, donor9 (control)	11927-125I1	36.54	2.93
Fibroblast - Lung, donor1	11270-116H1	6.80	1.36
Fibroblast - Lung, donor2	11347-117G6	56.70	5.97
Fibroblast - Lung, donor3	11419-118F6	22.37	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.28
Fibroblast - Mammary, donor1	11540-120B1	25.58	1.22
Fibroblast - Mammary, donor2	11620-122A9	11.98	3.99
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	61.10	6.21
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.32	3.94
Fibroblast - Periodontal Ligament, donor3	11395-118C9	93.33	5.20
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	3.43
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.08	4.32
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	21.11	2.44
Fibroblast - Pulmonary Artery, donor1	11250-116E8	67.98	4.20
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.63	3.05
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.12	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	58.74	7.14
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	53.64	6.93
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	76.47	7.88
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	45.13	5.42
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	72.11	9.72
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	56.18	7.34
Fibroblast - skin normal, donor1	11553-120C5	56.28	5.09
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	93.84	7.82
Fibroblast - skin normal, donor2	11561-120D4	65.70	10.25
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	71.93	8.16
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	66.69	6.30
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	74.36	7.52
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	53.21	6.24
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	81.17	9.05
Fibroblast - skin walker warburg, donor1	11554-120C6	52.97	5.06
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	55.98	8.15
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1573.35	88.64
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	48.02	4.16
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	65.06	7.29
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	50.34	6.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	43.64	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	75.29	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	90.71	5.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	53.77	4.96
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.78	3.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	61.02	5.15
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	39.12	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.18	4.89
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	95.96	7.96
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	64.58	4.80
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	53.57	4.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	53.73	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	57.86	5.20
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	54.26	3.32
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	56.72	3.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	39.02	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	46.34	3.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	38.25	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.98	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.55	4.13
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.89	4.47
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	38.11	2.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	62.26	5.09
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	81.40	4.70
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.08	6.97
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	84.88	8.03
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.81	5.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	71.96	4.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.56	3.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	51.78	2.89
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	48.08	3.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	43.53	3.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.13	3.53
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.12	4.43
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.39	3.24
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	49.07	4.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.45	5.02
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	36.70	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	44.40	5.17
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	48.71	4.08
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.76	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	45.45	3.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.94	2.69
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.59	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.45	3.21
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.58	2.85
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	40.12	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	39.08	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	43.42	3.51
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	40.66	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	35.09	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.29	3.43
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	79.81	5.85
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	112.07	5.97
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	69.18	4.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	81.01	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	49.76	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	55.95	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.03	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	56.92	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	63.44	3.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	81.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	58.91	5.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	82.77	8.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	62.08	3.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	64.06	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.39	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	57.74	3.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	59.56	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	38.77	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	54.21	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	71.24	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	60.75	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	59.20	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	56.07	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	48.16	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	70.12	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	90.72	4.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.99	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	50.09	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	53.41	6.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	58.63	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	66.11	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	47.22	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	76.43	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	62.32	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	35.22	4.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.50	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.08	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.06	3.34
Hep-2 cells mock treated, biol_rep1	11898-125E8	31.80	2.32
Hep-2 cells mock treated, biol_rep2	11899-125E9	31.73	2.87
Hep-2 cells mock treated, biol_rep3	11900-125F1	34.35	4.10
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	29.73	3.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	34.60	2.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	34.01	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	31.88	3.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	29.16	3.77
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.63	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.46	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.35	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	51.23	4.02
Hepatocyte, donor1	11523-119I2	36.32	8.47
Hepatocyte, donor2	11603-120I1	44.17	3.23
Hepatocyte, donor3	11684-122I1	35.59	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.66	9.14
Intestinal epithelial cells (polarized), donor1	11246-116E4	85.47	7.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	52.28	4.12
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.71	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.85	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	16.37	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.11	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	13.99	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.67	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	17.28	3.09
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	2.11
Keratinocyte - epidermal, donor1	11272-116H3	42.02	3.43
Keratinocyte - epidermal, donor2	11349-117G8	13.47	1.76
Keratinocyte - epidermal, donor3	11421-118F8	38.34	2.75
Keratinocyte - oral, donor1	11251-116E9	85.14	5.90
Keratocytes, donor1	11527-119I6	8.94	0.69
Keratocytes, donor2	11607-120I5	5.86	1.17
Keratocytes, donor3	11688-122I5	22.33	3.16
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	2.20
Lens Epithelial Cells, donor1	11529-119I8	37.76	3.24
Lens Epithelial Cells, donor2	11609-120I7	59.97	5.19
Lens Epithelial Cells, donor3	11690-122I7	64.28	5.55
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	27.51	1.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.84	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.55	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.91	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.35	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.24	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.77	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.30	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.70	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.45	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.67	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.60	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.12	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.89	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.94	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.55	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.08	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.84	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.73	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	21.01	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.93	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.68	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.98	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.56	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.63	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.23	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.55	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.42	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.69	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.01	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.33	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	22.52	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.34	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.42	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.98	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.97	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.45	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.07	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.94	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.97	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	9.06
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.98	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.16	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.66	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	28.21	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.06	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	33.06	3.66
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	38.46	3.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.98	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	4.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	43.49	4.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	38.92	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.09	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.40	3.75
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	32.79	5.32
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.68	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.09	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.30	3.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.56	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.34	5.90
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	27.63	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.79	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	33.40	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.05	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	28.92	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	5.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	22.41	5.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	25.27	5.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	25.84	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.98	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	25.32	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.32	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.06	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	25.23	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	17.51	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.26	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	21.15	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.21	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.26	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	25.30	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.64	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	25.41	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	6.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.78	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	27.61	4.01
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.03	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	30.35	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.73	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.51	4.81
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.52	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	28.16	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	25.47	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.59	4.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.74	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	21.44	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.36	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	29.79	3.49
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.32	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	20.11	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.74	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.05	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	25.38	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	37.59	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.89	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.56	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	25.42	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.59	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	24.25	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.35	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	27.61	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	24.62	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	32.07	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.69	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	4.16
Macrophage - monocyte derived, donor1	11232-116C8	41.25	2.73
Macrophage - monocyte derived, donor2	11313-117C8	42.76	3.12
Macrophage - monocyte derived, donor3	11389-118C3	29.62	2.49
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	48.85	4.25
Mallassez-derived cells, donor2	11929-125I3	82.71	6.97
Mallassez-derived cells, donor3	11930-125I4	84.37	8.34
Mammary Epithelial Cell, donor1	11273-116H4	65.27	5.78
Mammary Epithelial Cell, donor2	11350-117G9	51.54	5.50
Mammary Epithelial Cell, donor3	11422-118F9	14.97	2.49
Mast cell - stimulated, donor1	11487-119E2	128.13	8.81
Mast cell, donor1	11563-120D6	62.18	4.43
Mast cell, donor2	11565-120D8	44.87	3.27
Mast cell, donor3	11566-120D9	55.61	3.15
Mast cell, donor4	11567-120E1	51.95	4.25
Mast cell, expanded and stimulated, donor5	11940-126A5	73.63	5.21
Mast cell, expanded and stimulated, donor8	11942-126A7	50.20	6.42
Mast cell, expanded, donor5	11939-126A4	57.93	4.24
Mast cell, expanded, donor8	11941-126A6	51.55	4.02
Melanocyte - dark, donor1	11502-119F8	40.20	2.59
Melanocyte - dark, donor2	11582-120F7	27.34	1.38
Melanocyte - dark, donor3	11663-122F7	67.44	5.72
Melanocyte - light, donor1	11274-116H5	7.76	1.18
Melanocyte - light, donor2	11351-117H1	9.55	0.68
Melanocyte - light, donor3	11423-118G1	8.67	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	52.06	4.58
Melanocyte, donor2 (MC+2)	12739-135I3	33.62	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	39.37	1.87
Meningeal Cells, donor1	11493-119E8	22.58	2.73
Meningeal Cells, donor2	11573-120E7	12.32	2.64
Meningeal Cells, donor3	11654-122E7	91.61	6.76
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	55.32	4.85
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	47.20	3.62
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	50.95	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	43.41	4.87
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	31.16	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.48	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.23	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	36.70	4.29
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	56.71	3.42
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.46	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	84.36	8.86
Mesenchymal stem cells - hepatic, donor0	11218-116B3	41.59	3.13
Mesenchymal stem cells - umbilical, donor0	11214-116A8	41.36	2.18
Mesothelial Cells, donor1	11247-116E5	67.35	9.81
Mesothelial Cells, donor2	12156-128G5	46.54	4.50
Mesothelial Cells, donor3	11402-118D7	39.60	2.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	28.32	2.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.55	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	20.77	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.54	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	28.78	2.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.67	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.70	3.05
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	18.21	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.92	2.55
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.31	2.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.07	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.54	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.18	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.51	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.68	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	22.53	3.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.45	2.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.49	2.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.40	1.90
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	16.17	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.82	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.61	3.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.52	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.90	3.94
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	34.71	3.22
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	32.82	3.76
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	2.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.42	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.15	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	24.63	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.52	1.38
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	29.28	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.44	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.61	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	33.52	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.96	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.02	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	2.65
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.20	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	35.80	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	30.48	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.91	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.52	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	24.22	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	34.21	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.25	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.36	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	24.19	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.03	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	5.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	30.42	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.11	4.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	42.75	2.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	25.28	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	51.31	3.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	27.41	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	34.05	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	26.72	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	63.12	3.45
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	27.18	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.02	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.10	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.96	6.46
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	189.28	11.03
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.76	2.56
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.70	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.88	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	334.04	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.85	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.11	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.37	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.06	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	25.70	2.37
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.71	2.63
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.92	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.05	1.94
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.49	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.28	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	46.22	7.59
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	227.56	17.70
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.38	3.12
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.16	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.95	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	532.64	72.22
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.33	2.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.67	3.17
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.54	3.03
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.38	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.29	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.43	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.19	4.64
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.01	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	270.81	30.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.07	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.78	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	60.08	13.60
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	222.55	10.12
Myoblast, donor1	11241-116D8	57.64	6.09
Myoblast, donor2	11322-117D8	33.95	3.45
Myoblast, donor3	11398-118D3	59.03	5.72
NK T cell leukemia cell line:KHYG-1	10777-110G3	45.39	2.48
Natural Killer Cells, donor1	11230-116C6	67.65	1.54
Natural Killer Cells, donor2	11311-117C6	42.52	2.11
Natural Killer Cells, donor3	11387-118C1	44.36	2.21
Neural stem cells, donor1	11275-116H6	149.17	7.26
Neural stem cells, donor2	11352-117H2	194.49	36.59
Neurons, donor1	11494-119E9	127.44	15.93
Neurons, donor2	11574-120E8	128.36	13.65
Neurons, donor3	11655-122E8	97.84	9.04
Neutrophils, donor1	11233-116C9	33.41	0.93
Neutrophils, donor2	11314-117C9	14.49	2.90
Neutrophils, donor3	11390-118C4	63.53	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	53.43	4.39
Nucleus Pulposus Cell, donor2	11409-118E5	13.68	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	16.65	2.81
Olfactory epithelial cells, donor1	11933-125I7	24.91	2.34
Olfactory epithelial cells, donor2	11934-125I8	41.69	3.62
Olfactory epithelial cells, donor3	11935-125I9	30.53	2.72
Olfactory epithelial cells, donor4	11936-126A1	36.04	2.82
Oligodendrocyte - precursors, donor1	11496-119F2	70.41	7.82
Osteoblast - differentiated, donor1	11276-116H7	28.50	4.89
Osteoblast - differentiated, donor2	11353-117H3	11.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	13.66	0.62
Osteoblast, donor1	11277-116H8	18.18	1.76
Osteoblast, donor2	11354-117H4	75.85	6.32
Osteoblast, donor3	11426-118G4	27.55	3.20
Pancreatic stromal cells, donor1	11249-116E7	57.53	5.22
Pericytes, donor1	11491-119E6	4.34	0.56
Pericytes, donor2	11571-120E5	2.72	1.13
Pericytes, donor3	11652-122E5	12.82	1.22
Perineurial Cells, donor1	11499-119F5	61.03	3.16
Perineurial Cells, donor2	11579-120F4	57.41	3.59
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	56.42	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	23.26	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.32	1.55
Placental Epithelial Cells, donor1	11278-116H9	22.48	2.63
Placental Epithelial Cells, donor2	11355-117H5	27.72	1.11
Placental Epithelial Cells, donor3	11427-118G5	18.65	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.67	2.22
Preadipocyte - breast, donor1	11467-119B9	46.52	3.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	52.99	5.09
Preadipocyte - breast, donor2	11328-117E5	24.09	3.15
Preadipocyte - omental, donor1	11468-119C1	51.79	3.52
Preadipocyte - omental, donor2	11329-117E6	58.49	5.67
Preadipocyte - omental, donor3	11403-118D8	41.69	3.01
Preadipocyte - perirenal, donor1	11469-119C2	13.78	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	30.71	4.61
Preadipocyte - subcutaneous, donor2	11356-117H6	62.86	5.84
Preadipocyte - subcutaneous, donor3	11428-118G6	37.80	4.77
Preadipocyte - visceral, donor1	11280-116I2	87.37	6.61
Preadipocyte - visceral, donor2	11357-117H7	52.92	4.60
Preadipocyte - visceral, donor3	11429-118G7	39.08	3.87
Prostate Epithelial Cells (polarized), donor1	11253-116F2	84.02	6.64
Prostate Epithelial Cells, donor2	11331-117E8	31.01	3.39
Prostate Epithelial Cells, donor3	11404-118D9	27.92	4.59
Prostate Stromal Cells, donor1	11254-116F3	62.30	6.72
Prostate Stromal Cells, donor2	11332-117E9	41.78	3.05
Prostate Stromal Cells, donor3	11405-118E1	25.76	3.23
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.93	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	47.20	3.60
Renal Epithelial Cells, donor1	11517-119H5	4.06	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	0.00
Renal Epithelial Cells, donor3	11678-122H4	56.21	3.39
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.09	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.30	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.38	0.88
Renal Mesangial Cells, donor2	11598-120H5	8.15	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	23.35	2.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	7.17	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.91	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	56.78	3.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.92	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	37.89	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	59.87	6.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	97.97	5.50
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	49.88	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	66.44	4.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	43.30	4.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	85.89	5.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	90.18	8.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	52.68	3.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	71.42	5.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	43.67	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.68	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	57.88	4.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	43.90	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	45.72	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	44.48	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	44.54	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	42.39	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	96.58	6.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.78	4.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	48.96	3.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	60.92	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	40.05	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	48.21	5.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	49.73	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	34.64	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.86	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	47.01	4.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	58.26	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	47.02	4.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	55.42	3.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	49.35	4.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	49.11	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	42.82	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	45.09	4.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	39.00	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	44.54	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	53.99	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	35.39	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.27	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	39.71	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.85	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.18	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	35.40	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	49.53	3.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	53.81	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	40.12	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	53.10	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	40.80	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	38.92	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	124.59	9.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	58.41	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.62	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	40.94	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.12	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	52.66	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	43.33	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	48.08	1.20
Schwann Cells, donor1	11498-119F4	4.14	0.75
Schwann Cells, donor2	11578-120F3	37.43	6.80
Schwann Cells, donor3	11659-122F3	35.05	1.75
Sebocyte, donor1	11220-116B5	26.84	3.29
Sebocyte, donor2	11301-117B5	21.60	0.92
Sebocyte, donor3	11378-118B1	16.28	2.47
Sertoli Cells, donor1	11255-116F4	66.26	3.31
Sertoli Cells, donor2	11333-117F1	42.37	5.65
Skeletal Muscle Cells, donor1	11281-116I3	35.37	2.73
Skeletal Muscle Cells, donor2	11358-117H8	2.17	0.72
Skeletal Muscle Cells, donor3	11430-118G8	20.06	3.34
Skeletal Muscle Cells, donor4	11451-119A2	33.93	4.08
Skeletal Muscle Cells, donor5	11455-119A6	36.72	3.57
Skeletal Muscle Cells, donor6	11459-119B1	46.94	5.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	57.84	4.16
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.53	3.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	52.68	4.96
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	58.05	5.14
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	4.34	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.70	2.06
Skin - palm, donor1	10286-104F7	21.49	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.88	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	46.62	5.73
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.32	2.08
Small Airway Epithelial Cells, donor1	11256-116F5	53.24	7.65
Small Airway Epithelial Cells, donor2	11334-117F2	23.35	2.39
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	77.39	6.13
Small Airway Epithelial Cells, donor3	11406-118E2	25.26	3.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.41	5.55
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.35	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.75	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	25.64	2.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.63	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	42.49	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	39.03	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.29	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.89	5.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	30.22	5.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	43.30	3.58
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	62.90	5.32
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.32	2.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.86	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.61	2.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	20.71	3.03
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	47.34	2.80
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.20	2.80
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.69	3.25
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.84	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.35	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.92	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	54.66	4.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	60.89	4.53
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.96	2.05
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	109.41	7.95
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.73	6.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.07	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	28.16	4.82
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	49.00	4.82
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.44	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	29.28	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.42	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.90	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	82.39	6.41
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.63	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	25.19	2.59
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.18	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.28	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	77.00	7.27
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	65.10	5.11
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.71	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	52.14	7.73
Smooth Muscle Cells - Uterine, donor3	11466-119B8	63.20	6.44
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.72	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.18	3.44
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	49.47	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	36.65	3.23
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.42	2.84
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	41.75	4.73
Smooth muscle cells - airway, control, donor1	11966-126D4	30.22	5.08
Smooth muscle cells - airway, control, donor2	11967-126D5	25.96	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	24.75	2.75
Synoviocyte, donor1	11291-117A4	50.66	6.40
Synoviocyte, donor2	11368-117I9	34.87	2.01
Synoviocyte, donor3	11440-118H9	21.89	2.46
Trabecular Meshwork Cells, donor1	11532-120A2	14.65	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.34	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	32.97	2.94
Tracheal Epithelial Cells, donor2	11369-118A1	12.37	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	65.33	5.78
Urethra, donor2	10319-105A4	34.17	1.80
Urothelial Cells, donor1	11520-119H8	6.11	0.53
Urothelial Cells, donor2	11600-120H7	4.81	0.40
Urothelial Cells, donor3	11681-122H7	2.52	0.92
Urothelial cells, donor0	11216-116B1	53.94	5.13
Whole blood (ribopure), donor090309, donation1	12179-129A1	71.18	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	67.19	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	65.08	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	62.17	4.65
Whole blood (ribopure), donor090612, donation1	12182-129A4	55.19	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	55.99	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	2.74
Wilms' tumor cell line:G-401	10809-111A8	33.18	4.56
Wilms' tumor cell line:HFWT	10597-108E3	31.68	7.92
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	57.26	3.91
achilles tendon, donor2	10292-104G4	14.47	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	35.95	3.06
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	122.36	6.04
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	97.58	9.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	124.63	8.44
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	75.05	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	90.51	4.65
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	39.47	2.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	59.49	4.85
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	66.97	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	67.18	7.38
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	71.76	4.78
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	32.30	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	113.66	10.10
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	99.36	9.35
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	29.28	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	46.88	3.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.81	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	129.72	11.09
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	127.99	11.22
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	129.50	12.28
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	55.24	4.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	60.04	6.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	42.74	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	76.84	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	54.52	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	1.87
adenocarcinoma cell line:IM95m	10796-110I4	36.74	6.36
adipose tissue, adult, pool1	10010-101C1	40.49	2.79
adipose, donor1	10184-103D4	113.76	11.73
adipose, donor2	10185-103D5	23.52	2.84
adipose, donor3	10186-103D6	46.29	5.45
adipose, donor4	10187-103D7	54.61	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	55.39	6.63
adrenal gland, adult, pool1	10081-102A9	10.91	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	53.63	3.87
alveolar cell carcinoma cell line:SW 1573	10708-109H6	56.45	6.07
amniotic membrane cells, donor1	12235-129G3	69.32	10.90
amniotic membrane cells, donor2	12236-129G4	77.09	10.82
amniotic membrane cells, donor3	12237-129G5	51.56	12.37
amygdala - adult, donor10196	10167-103B5	74.71	15.42
amygdala, adult, donor10252	10151-102I7	54.34	10.14
amygdala, newborn, donor10223	10360-105E9	41.64	9.36
anaplastic carcinoma cell line:8305C	10428-106D5	31.07	3.44
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	56.04	4.41
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	38.41	2.67
aorta, adult, pool1	10052-101G7	19.42	2.16
appendix, adult	10189-103D9	36.48	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	102.84	12.73
artery, adult	10190-103E1	42.12	6.79
astrocytoma cell line:TM-31	10425-106D2	96.77	5.22
b cell line:RPMI1788	10427-106D4	58.74	6.99
basal cell carcinoma cell line:TE 354.T	10702-109G9	61.32	7.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.17	3.87
bile duct carcinoma cell line:TFK-1	10496-107C1	39.67	4.35
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	27.96	1.68
bladder, adult, pool1	10011-101C2	32.59	4.13
blood, adult, pool1	10053-101G8	22.15	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.96	5.14
bone marrow, adult	10192-103E3	44.54	3.37
brain, adult, donor1	10084-102B3	31.78	1.03
brain, adult, pool1	10012-101C3	69.04	9.69
brain, fetal, pool1	10085-102B4	26.71	18.70
breast carcinoma cell line:MCF7	10482-107A5	40.30	9.58
breast carcinoma cell line:MDA-MB-453	10419-106C5	61.41	7.24
breast, adult, donor1	10080-102A8	19.57	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	67.84	5.08
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	32.78	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	122.02	8.98
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	32.92	3.63
carcinoid cell line:NCI-H1770	10703-109H1	59.24	4.70
carcinoid cell line:NCI-H727	10735-110B6	23.95	3.50
carcinoid cell line:SK-PN-DW	10719-109I8	55.14	5.39
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.69	5.06
caudate nucleus - adult, donor10196	10177-103C6	43.75	4.61
caudate nucleus, adult, donor10252	10164-103B2	43.67	12.72
caudate nucleus, adult, donor10258	10379-105H1	34.39	6.88
caudate nucleus, newborn, donor10223	10354-105E3	43.22	9.16
cerebellum - adult, donor10196	10173-103C2	81.57	11.65
cerebellum, adult, donor10252	10166-103B4	81.13	6.83
cerebellum, adult, pool1	10083-102B2	33.80	3.45
cerebellum, newborn, donor10223	10357-105E6	73.90	9.96
cerebral meninges, adult	10188-103D8	34.04	9.83
cerebrospinal fluid, donor2	10294-104G6	20.46	2.19
cervical cancer cell line:D98-AH2	10552-107I3	45.15	3.16
cervical cancer cell line:ME-180	10553-107I4	63.80	3.31
cervix, adult, pool1	10013-101C4	47.56	5.56
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	75.66	7.25
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	2.61
choriocarcinoma cell line:BeWo	10423-106C9	67.98	4.72
choriocarcinoma cell line:SCH	10785-110H2	39.06	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	41.98	4.27
chorionic membrane cells, donor1	12238-129G6	43.88	7.12
chorionic membrane cells, donor2	12239-129G7	71.49	6.16
chorionic membrane cells, donor3	12240-129G8	63.19	5.49
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	51.50	10.10
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	92.21	9.60
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	64.62	4.86
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	58.55	6.68
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	52.73	6.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	59.86	8.14
chronic myelogenous leukemia cell line:K562	10454-106G4	79.80	8.24
chronic myelogenous leukemia cell line:KU812	10409-106B4	184.26	8.86
clear cell carcinoma cell line:JHOC-5	10638-108I8	52.12	4.80
clear cell carcinoma cell line:TEN	10636-108I6	52.75	5.73
colon carcinoma cell line:CACO-2	10513-107D9	105.07	10.43
colon carcinoma cell line:COLO-320	10420-106C6	96.54	10.64
colon, adult, donor1	10082-102B1	17.85	2.38
colon, adult, pool1	10014-101C5	48.29	5.29
colon, fetal, donor1	10070-101I7	40.17	4.94
common myeloid progenitor CMP, donor1	12130-128D6	45.84	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	84.14	8.92
cord blood derived cell line:COBL-a 24h infection	10453-106G3	101.88	5.89
cord blood derived cell line:COBL-a untreated	10449-106F8	114.92	7.05
corpus callosum, adult, pool1	10042-101F6	57.27	7.85
cruciate ligament, donor2	10295-104G7	23.50	2.43
diaphragm, fetal, donor1	10069-101I6	24.88	2.41
diencephalon, adult	10193-103E4	47.52	7.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	56.03	4.59
ductal cell carcinoma cell line:KLM-1	10438-106E6	72.32	7.18
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	46.22	4.81
ductus deferens, adult	10196-103E7	22.43	3.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.97	4.41
dura mater, adult, donor1	10041-101F5	43.36	2.56
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	92.16	14.88
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	111.77	11.18
embryonic pancreas cell line:1B2C6	10604-108F1	25.28	3.70
embryonic pancreas cell line:1C3D3	10605-108F2	40.26	4.84
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.10	2.16
embryonic pancreas cell line:2C6	10603-108E9	44.66	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	62.68	4.36
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	55.64	5.98
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	60.30	5.63
epidermoid carcinoma cell line:A431	10426-106D3	74.59	6.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	55.43	5.61
epididymis, adult	10197-103E8	26.79	4.60
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.27	4.44
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.90	7.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.57	5.11
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.77	3.64
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	57.81	4.26
esophagus, adult, pool1	10015-101C6	47.89	3.72
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	81.03	8.77
eye - muscle inferior rectus, donor1	10272-104E2	14.49	2.41
eye - muscle lateral, donor2	10298-104H1	31.56	6.31
eye - muscle medial, donor2	10299-104H2	17.86	5.95
eye - muscle superior, donor2	10297-104G9	16.05	4.59
eye - vitreous humor, donor1	10268-104D7	14.57	4.37
eye, fetal, donor1	10054-101G9	50.08	6.86
fibrosarcoma cell line:HT-1080	10758-110E2	57.32	2.56
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	74.07	9.02
frontal lobe, adult, pool1	10040-101F4	104.33	19.14
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	106.89	5.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	76.26	7.86
gall bladder, adult	10198-103E9	18.59	2.17
gamma delta positive T cells, donor1	11937-126A2	60.13	4.29
gamma delta positive T cells, donor2	11938-126A3	54.90	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	71.39	8.03
gastric adenocarcinoma cell line:MKN45	10612-108F9	76.79	10.44
gastric cancer cell line:AZ521	10549-107H9	92.31	10.00
gastric cancer cell line:GSS	10560-108A2	43.02	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	37.70	3.66
giant cell carcinoma cell line:LU65	10487-107B1	63.68	9.98
giant cell carcinoma cell line:Lu99B	10433-106E1	69.56	7.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.40	6.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	56.15	6.44
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.05	5.62
glioblastoma cell line:T98G	10485-107A8	48.45	5.08
glioma cell line:GI-1	10413-106B8	52.43	4.10
globus pallidus - adult, donor10196	10175-103C4	36.45	6.56
globus pallidus, adult, donor10252	10161-103A8	53.21	9.76
globus pallidus, adult, donor10258	10367-105F7	27.38	5.48
globus pallidus, newborn, donor10223	10364-105F4	21.32	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	30.40	3.20
hIPS +CCl2, biol_rep1	14383-156B9	67.95	5.05
hIPS +CCl2, biol_rep2	14384-156C1	62.19	4.12
hIPS +CCl2, biol_rep3	14385-156C2	47.66	1.93
hIPS, biol_rep1	14380-156B6	34.49	1.44
hIPS, biol_rep2	14381-156B7	38.41	4.12
hIPS, biol_rep3	14382-156B8	43.04	4.41
hairy cell leukemia cell line:Mo	10712-109I1	44.54	5.17
heart - mitral valve, adult	10205-103F7	28.40	3.29
heart - pulmonic valve, adult	10206-103F8	32.16	3.40
heart - tricuspid valve, adult	10207-103F9	24.98	5.83
heart, adult, diseased post-infarction, donor1	10050-101G5	26.94	1.63
heart, adult, diseased, donor1	10051-101G6	17.88	2.13
heart, adult, pool1	10016-101C7	20.01	2.99
heart, fetal, pool1	10046-101G1	81.01	6.16
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.38	2.78
hepatoblastoma cell line:HuH-6	10633-108I3	15.46	7.14
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	128.62	6.96
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	140.19	7.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	138.44	7.68
hepatoma cell line:Li-7	10484-107A7	63.62	7.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.92	2.91
hippocampus - adult, donor10196	10169-103B7	50.16	11.36
hippocampus, adult, donor10252	10153-102I9	51.64	7.35
hippocampus, adult, donor10258	10374-105G5	36.35	9.96
hippocampus, newborn, donor10223	10363-105F3	35.60	6.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	117.80	7.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	66.96	3.73
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	56.36	3.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	41.16	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.38	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	48.97	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	43.21	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	54.29	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.37	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	89.51	8.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	65.73	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	88.88	5.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	71.51	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	67.80	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	115.20	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.25	4.20
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	47.53	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	40.98	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	57.08	5.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	60.02	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	44.48	4.07
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	56.50	3.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	55.45	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.95	3.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	67.99	4.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	69.89	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	86.97	6.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	47.18	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.88	4.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.34	4.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	42.40	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	46.49	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.53	4.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	53.69	4.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	42.40	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	51.08	5.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	66.41	3.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	62.84	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	60.00	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	49.82	4.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	435.93	52.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	68.51	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	52.54	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.62	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.94	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	95.07	7.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	43.10	2.96
immature langerhans cells, donor1	11904-125F5	31.24	2.66
immature langerhans cells, donor2	11905-125F6	21.39	0.79
insula, adult, pool1	10039-101F3	88.20	14.10
keratoacanthoma cell line:HKA-1	10791-110H8	38.69	1.95
kidney, adult, pool1	10017-101C8	58.67	4.91
kidney, fetal, pool1	10045-101F9	33.46	3.68
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.13	3.98
large cell lung carcinoma cell line:NCI-H460	10839-111E2	18.52	1.94
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.09	3.49
left atrium, adult, donor1	10079-102A7	18.52	1.09
left ventricle, adult, donor1	10078-102A6	18.71	3.54
leiomyoblastoma cell line:G-402	10721-110A1	28.73	2.74
leiomyoma cell line:10964C	10569-108B2	29.10	4.31
leiomyoma cell line:15242A	10570-108B3	30.43	6.52
leiomyoma cell line:15425	10571-108B4	29.87	5.58
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	50.19	10.46
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	75.68	2.83
liposarcoma cell line:KMLS-1	10782-110G8	78.89	8.12
liposarcoma cell line:SW 872	10726-110A6	25.83	1.71
liver, adult, pool1	10018-101C9	52.99	4.70
liver, fetal, pool1	10086-102B5	15.99	2.82
locus coeruleus - adult, donor10196	10182-103D2	34.12	5.10
locus coeruleus, adult, donor10252	10165-103B3	46.51	8.30
locus coeruleus, adult, donor10258	10375-105G6	27.09	3.10
locus coeruleus, newborn, donor10223	10362-105F2	68.14	10.94
lung adenocarcinoma cell line:A549	10499-107C4	27.68	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	50.33	10.34
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	17.14	1.98
lung, adult, pool1	10019-101D1	28.35	3.19
lung, fetal, donor1	10068-101I5	73.64	11.13
lung, right lower lobe, adult, donor1	10075-102A3	19.25	1.37
lymph node, adult, donor1	10077-102A5	29.82	0.95
lymphangiectasia cell line:DS-1	10727-110A7	31.12	3.73
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	84.52	6.19
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	106.19	7.65
mature adipocyte, donor1	12231-129F8	23.98	2.22
mature adipocyte, donor2	12232-129F9	28.02	4.15
mature adipocyte, donor3	12233-129G1	28.68	4.27
mature adipocyte, donor4	12234-129G2	44.75	5.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	73.38	11.91
medial frontal gyrus - adult, donor10196	10170-103B8	71.07	21.43
medial frontal gyrus, adult, donor10252	10150-102I6	54.44	8.83
medial frontal gyrus, adult, donor10258	10368-105F8	45.43	11.12
medial frontal gyrus, newborn, donor10223	10352-105E1	157.80	26.87
medial temporal gyrus - adult, donor10196	10183-103D3	67.16	12.15
medial temporal gyrus, adult, donor10252	10156-103A3	61.12	8.28
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	387.55	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	54.56	10.05
medulla oblongata - adult, donor10196	10174-103C3	35.04	3.24
medulla oblongata, adult, donor10252	10155-103A2	45.98	9.60
medulla oblongata, adult, pool1	10038-101F2	49.55	7.10
medulla oblongata, newborn, donor10223	10361-105F1	36.11	6.60
medulloblastoma cell line:D283 Med	10838-111E1	77.94	5.31
medulloblastoma cell line:ONS-76	10759-110E3	30.81	3.18
melanoma cell line:COLO 679	10514-107E1	37.66	4.02
melanoma cell line:G-361	10465-106H6	37.19	3.80
meningioma cell line:HKBMM	10691-109F7	17.01	2.53
merkel cell carcinoma cell line:MKL-1	10843-111E6	63.44	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	121.58	10.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	52.63	5.98
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.90	5.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	31.06	4.97
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.75	5.34
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.97	4.24
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	33.13	5.66
mesenchymal precursor cell - cardiac, donor2	11753-123G7	31.05	4.49
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.96	5.31
mesenchymal precursor cell - cardiac, donor4	11755-123G9	50.37	5.40
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	41.83	4.55
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.67	2.31
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	40.82	2.63
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	41.89	4.89
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	36.14	6.94
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.49	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.52	3.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.27	4.56
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	91.46	10.49
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.93	3.59
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.17	4.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	28.72	2.58
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.89	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	69.47	5.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.94	4.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	47.83	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	33.77	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	35.43	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	45.66	3.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.29	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	39.30	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.85	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	44.99	4.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	40.38	4.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	38.94	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.73	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.91	3.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	36.03	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	43.81	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	28.91	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.59	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	24.10	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	19.87	4.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	28.46	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	22.17	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.07	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	19.45	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.57	2.49
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.22	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.14	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	21.63	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.96	3.37
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.44	2.92
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.08	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	77.01	12.52
mesothelioma cell line:ACC-MESO-4	10494-107B8	82.24	8.57
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	98.29	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	110.25	5.34
mesothelioma cell line:Mero-25	10850-111F4	42.21	4.99
mesothelioma cell line:Mero-41	10851-111F5	42.78	5.13
mesothelioma cell line:Mero-48a	10852-111F6	67.54	7.53
mesothelioma cell line:Mero-82	10853-111F7	42.84	3.15
mesothelioma cell line:Mero-83	10854-111F8	32.00	3.23
mesothelioma cell line:Mero-84	10855-111F9	53.34	4.30
mesothelioma cell line:Mero-95	10856-111G1	48.24	3.52
mesothelioma cell line:NCI-H2052	10847-111F1	41.41	4.47
mesothelioma cell line:NCI-H226	10846-111E9	79.27	5.61
mesothelioma cell line:NCI-H2452	10848-111F2	89.85	7.35
mesothelioma cell line:NCI-H28	10845-111E8	49.62	6.36
mesothelioma cell line:No36	10857-111G2	39.14	2.94
mesothelioma cell line:ONE58	10858-111G3	62.59	5.69
migratory langerhans cells, donor1	11901-125F2	34.55	5.37
migratory langerhans cells, donor2	11902-125F3	37.25	4.15
migratory langerhans cells, donor3	11903-125F4	49.72	3.59
mixed mullerian tumor cell line:HTMMT	10689-109F5	70.85	6.86
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	53.83	3.18
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	18.89	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	30.26	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	121.96	9.98
myeloma cell line:PCM6	10474-106I6	41.11	1.98
myxofibrosarcoma cell line:MFH-ino	10600-108E6	23.34	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	42.37	4.12
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.66	6.02
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.61	6.18
nasal epithelial cells, donor2	12227-129F4	37.54	4.42
neuroblastoma cell line:CHP-134	10508-107D4	105.83	6.21
neuroblastoma cell line:NB-1	10539-107G8	121.61	11.41
neuroblastoma cell line:NBsusSR	10607-108F4	82.88	7.38
neuroblastoma cell line:NH-12	10555-107I6	78.64	5.96
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	31.79	4.51
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	63.35	12.99
neuroectodermal tumor cell line:TASK1	10774-110F9	77.48	3.02
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.07	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	26.62	3.46
neutrophil PMN, donor1	12133-128D9	14.87	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28
neutrophil PMN, donor3	12141-128E8	104.18	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	238.29	10.65
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	31.22	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.47	3.21
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.47	2.89
nucleus accumbens, adult, pool1	10037-101F1	73.77	14.06
occipital cortex - adult, donor10196	10172-103C1	65.93	10.30
occipital cortex, adult, donor10252	10163-103B1	51.53	11.81
occipital cortex, newborn, donor10223	10355-105E4	58.23	11.65
occipital lobe, adult, donor1	10076-102A4	60.88	8.92
occipital lobe, fetal, donor1	10073-102A1	139.89	25.75
occipital pole, adult, pool1	10036-101E9	32.72	5.76
olfactory region, adult	10195-103E6	42.22	11.27
optic nerve, donor1	10277-104E7	32.02	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	86.00	9.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	76.52	6.59
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.85	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	51.86	3.93
osteoclastoma cell line:Hs 706.T	10704-109H2	30.57	4.41
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	37.37	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	45.38	4.24
ovary, adult, pool1	10020-101D2	34.07	3.32
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	24.01	2.57
pancreas, adult, donor1	10049-101G4	17.87	6.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	33.54	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	65.07	6.13
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	50.01	3.15
paracentral gyrus, adult, pool1	10035-101E8	74.96	12.90
parietal cortex, adult, donor10258	10373-105G4	52.11	4.40
parietal lobe - adult, donor10196	10171-103B9	52.67	10.35
parietal lobe, adult, donor10252	10157-103A4	54.73	8.27
parietal lobe, adult, pool1	10034-101E7	68.56	12.95
parietal lobe, fetal, donor1	10072-101I9	132.87	17.46
parietal lobe, newborn, donor10223	10356-105E5	66.92	12.71
parotid gland, adult	10199-103F1	20.97	3.08
penis, adult	10200-103F2	34.91	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	71.21	16.55
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	73.43	4.95
pineal gland - adult, donor10196	10179-103C8	30.96	4.52
pineal gland, adult, donor10252	10160-103A7	113.70	10.66
pineal gland, adult, donor10258	10377-105G8	25.08	3.76
pituitary gland - adult, donor10196	10180-103C9	44.52	9.11
pituitary gland, adult, donor10252	10162-103A9	98.50	10.94
pituitary gland, adult, donor10258	10378-105G9	29.79	3.40
placenta, adult, pool1	10021-101D3	64.29	5.91
plasma cell leukemia cell line:ARH-77	10840-111E3	54.30	4.37
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	66.15	9.81
pons, adult, pool1	10033-101E6	73.24	10.67
postcentral gyrus, adult, pool1	10032-101E5	57.71	10.37
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	53.60	3.20
prostate cancer cell line:PC-3	10439-106E7	63.34	3.63
prostate, adult, pool1	10022-101D4	39.00	4.35
putamen, adult, donor10196	10176-103C5	61.14	11.80
putamen, adult, donor10252	10152-102I8	39.21	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	34.55	7.73
putamen, newborn, donor10223	10365-105F5	98.96	14.99
rectal cancer cell line:TT1TKB	10469-106I1	55.86	6.11
rectum, fetal, donor1	10067-101I4	41.73	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.55	5.94
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	48.88	7.87
retina, adult, pool1	10030-101E3	33.80	2.78
retinoblastoma cell line:Y79	10475-106I7	75.34	4.68
rhabdomyosarcoma cell line:KYM-1	10787-110H4	77.70	6.27
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	41.34	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	2.27
salivary acinar cells, donor1	11771-123I7	36.58	2.27
salivary acinar cells, donor2	11772-123I8	34.83	2.75
salivary acinar cells, donor3	11773-123I9	21.85	1.99
salivary gland, adult, pool1	10093-102C3	25.17	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	56.24	7.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	58.66	6.70
seminal vesicle, adult	10201-103F3	20.10	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	29.15	6.07
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	37.24	5.28
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	55.19	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	34.12	5.10
signet ring carcinoma cell line:Kato III	10436-106E4	63.00	6.85
signet ring carcinoma cell line:NUGC-4	10483-107A6	43.48	4.00
skeletal muscle - soleus muscle, donor1	10282-104F3	36.18	5.67
skeletal muscle, adult, pool1	10023-101D5	58.29	7.56
skeletal muscle, fetal, donor1	10066-101I3	22.11	5.03
skin, adult, donor1	10074-102A2	13.57	0.00
skin, fetal, donor1	10065-101I2	51.13	6.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	51.03	3.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	80.38	4.41
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.26	11.95
small cell lung carcinoma cell line:LK-2	10541-107H1	115.05	9.56
small cell lung carcinoma cell line:NCI-H82	10842-111E5	59.68	9.49
small cell lung carcinoma cell line:WA-hT	10562-108A4	95.01	7.41
small intestine, adult, pool1	10024-101D6	92.21	9.44
small intestine, fetal, donor1	10064-101I1	63.64	5.65
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.13	5.64
smooth muscle, adult, pool1	10048-101G3	18.61	2.58
somatostatinoma cell line:QGP-1	10781-110G7	23.59	2.41
spinal cord - adult, donor10196	10181-103D1	41.52	7.57
spinal cord, adult, donor10252	10159-103A6	61.11	9.86
spinal cord, adult, donor10258	10369-105F9	46.35	6.92
spinal cord, fetal, donor1	10056-101H2	46.35	7.93
spinal cord, newborn, donor10223	10359-105E8	58.32	7.81
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	31.66	4.93
spleen, adult, pool1	10025-101D7	47.36	2.75
spleen, fetal, pool1	10044-101F8	37.11	2.07
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.88	3.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	78.42	3.99
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	49.97	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.48	7.04
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.48	6.75
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.08	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	41.46	4.23
stomach, fetal, donor1	10062-101H8	34.18	3.20
submaxillary gland, adult	10202-103F4	25.07	1.14
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55
substantia nigra, adult, donor10252	10158-103A5	53.38	9.76
substantia nigra, adult, donor10258	10371-105G2	35.69	4.14
substantia nigra, newborn, donor10223	10358-105E7	36.74	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	83.22	9.86
temporal lobe, adult, pool1	10031-101E4	36.54	6.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	83.34	24.22
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	90.98	10.55
tenocyte, donor1	11763-123H8	35.96	4.54
tenocyte, donor2	11765-123I1	35.86	3.05
tenocyte, donor3	11768-123I4	51.89	5.19
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	98.07	7.31
teratocarcinoma cell line:NCR-G1	10798-110I6	49.02	3.08
teratocarcinoma cell line:PA-1	10807-111A6	58.12	3.41
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	47.22	3.30
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	90.38	6.81
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.27	4.25
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	87.29	7.82
testis, adult, pool1	10026-101D8	48.96	5.05
testis, adult, pool2	10096-102C6	35.64	5.41
thalamus - adult, donor10196	10168-103B6	34.22	7.73
thalamus, adult, donor10252	10154-103A1	51.57	9.22
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.20	3.46
thalamus, newborn, donor10223	10366-105F6	62.13	18.41
throat, adult	10209-103G2	39.70	4.74
throat, fetal, donor1	10061-101H7	39.31	5.18
thymic carcinoma cell line:Ty-82	10803-111A2	55.25	3.97
thymus, adult, pool1	10027-101D9	82.12	7.46
thymus, fetal, pool1	10043-101F7	84.89	9.97
thyroid carcinoma cell line:KHM-5M	10776-110G2	30.85	3.59
thyroid carcinoma cell line:TCO-1	10783-110G9	48.61	4.33
thyroid, adult, pool1	10028-101E1	44.88	5.69
thyroid, fetal, donor1	10060-101H6	31.90	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	6.16
tongue, adult	10203-103F5	48.38	5.12
tongue, fetal, donor1	10059-101H5	61.08	8.28
tonsil, adult, pool1	10047-101G2	53.49	5.51
trachea, adult, pool1	10029-101E2	45.64	4.99
trachea, fetal, donor1	10058-101H4	37.32	5.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	37.91	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	85.51	4.05
transitional-cell carcinoma cell line:JMSU1	10492-107B6	72.39	7.52
tridermal teratoma cell line:HGRT	10694-109G1	30.44	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.27	3.39
umbilical cord, fetal, donor1	10057-101H3	22.95	6.26
uterus, adult, pool1	10100-102D1	34.30	3.41
uterus, fetal, donor1	10055-101H1	47.10	5.63
vagina, adult	10204-103F6	25.20	3.88
vein, adult	10191-103E2	23.24	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	37.65	2.40